Cargando…

Tofacitinib in Refractory Scleritis: A Case Series

Tofacitinib, a Janus kinase inhibitor, has been recently investigated as a potential therapy for refractory scleritis. Despite treatment with systemic immunosuppressive agents, scleritis is refractory to conventional therapy in a significant number of patients. Hereby, we report the use of tofacitin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dey, Suvankar, Sarkar, Rajdeep, Pradhan, Amrita, Padhan, Prasanta, Maikap, Debashis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628867/
https://www.ncbi.nlm.nih.gov/pubmed/37941862
http://dx.doi.org/10.31138/mjr.20230828.ti

Ejemplares similares